tiprankstipranks
Travere Therapeutics price target raised to $22 from $12 at Piper Sandler
PremiumThe FlyTravere Therapeutics price target raised to $22 from $12 at Piper Sandler
2M ago
Travere Therapeutics 7.81M share Spot Secondary priced at $16.00
Premium
The Fly
Travere Therapeutics 7.81M share Spot Secondary priced at $16.00
2M ago
Travere Therapeutics announces common stock offering, no amount given
Premium
The Fly
Travere Therapeutics announces common stock offering, no amount given
2M ago
Travere presents data reinforcing clinical benefit of FILSPARI in IgAN
PremiumThe FlyTravere presents data reinforcing clinical benefit of FILSPARI in IgAN
3M ago
Wells Fargo upgrades Travere Therapeutics to Overweight on further upside
Premium
The Fly
Wells Fargo upgrades Travere Therapeutics to Overweight on further upside
3M ago
Travere Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
Travere Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
3M ago
Travere Therapeutics price target raised to $30 from $12 at Evercore ISI
PremiumThe FlyTravere Therapeutics price target raised to $30 from $12 at Evercore ISI
3M ago
Travere Therapeutics price target raised to $25 from $17 at Wedbush
Premium
The Fly
Travere Therapeutics price target raised to $25 from $17 at Wedbush
3M ago
Travere Therapeutics price target raised to $20 from $18 at BofA
Premium
The Fly
Travere Therapeutics price target raised to $20 from $18 at BofA
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100